JOHNSON INVESTMENT COUNSEL INC has added 508,087 shares of $CL to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $CL.
COLGATE-PALMOLIVE Hedge Fund Activity
We have seen 741 institutional investors add shares of COLGATE-PALMOLIVE stock to their portfolio, and 1,016 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 18,376,766 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $1,452,132,049
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 4,598,789 shares (+8040.1%) to their portfolio in Q4 2025, for an estimated $363,396,306
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 4,282,241 shares (-80.7%) from their portfolio in Q4 2025, for an estimated $338,382,683
- PRICE T ROWE ASSOCIATES INC /MD/ removed 4,206,156 shares (-11.5%) from their portfolio in Q3 2025, for an estimated $336,240,110
- GQG PARTNERS LLC removed 3,969,183 shares (-34.9%) from their portfolio in Q4 2025, for an estimated $313,644,840
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 3,814,556 shares (+591.9%) to their portfolio in Q3 2025, for an estimated $304,935,606
- DEUTSCHE BANK AG\ added 2,746,920 shares (+33.9%) to their portfolio in Q4 2025, for an estimated $217,061,618
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
COLGATE-PALMOLIVE Insider Trading Activity
COLGATE-PALMOLIVE insiders have traded $CL stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CL stock by insiders over the last 6 months:
- STANLEY J III SUTULA (Chief Financial Officer) sold 97,843 shares for an estimated $9,223,287
- PANAGIOTIS TSOURAPAS (COO, Eur., APac, Afr Eur, Skin) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $4,778,436.
- NOEL R. WALLACE (Chairman, President & CEO) sold 45,568 shares for an estimated $4,279,495
- JENNIFER DANIELS (CLO and Secretary) sold 22,000 shares for an estimated $2,075,398
- JOHN HAZLIN (Chief Growth Officer) sold 20,989 shares for an estimated $1,978,211
- SALLY MASSEY (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 17,088 shares for an estimated $1,606,348.
- GREGORY MALCOLM (EVP and Controller) sold 12,747 shares for an estimated $1,209,821
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
COLGATE-PALMOLIVE Congressional Stock Trading
Members of Congress have traded $CL stock 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CL stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICK LARSEN sold up to $15,000 on 10/06.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/11.
- REPRESENTATIVE TIM MOORE sold up to $15,000 on 09/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
COLGATE-PALMOLIVE Analyst Ratings
Wall Street analysts have issued reports on $CL in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 12/18/2025
- RBC Capital issued a "Outperform" rating on 12/09/2025
- Citigroup issued a "Buy" rating on 11/03/2025
- UBS issued a "Buy" rating on 11/03/2025
- Evercore ISI Group issued a "Outperform" rating on 11/03/2025
- Morgan Stanley issued a "Overweight" rating on 11/03/2025
- Goldman Sachs issued a "Buy" rating on 10/02/2025
To track analyst ratings and price targets for COLGATE-PALMOLIVE, check out Quiver Quantitative's $CL forecast page.
COLGATE-PALMOLIVE Price Targets
Multiple analysts have issued price targets for $CL recently. We have seen 15 analysts offer price targets for $CL in the last 6 months, with a median target of $94.0.
Here are some recent targets:
- Lauren Lieberman from Barclays set a target price of $88.0 on 02/03/2026
- Kaumil Gajrawala from Jefferies set a target price of $91.0 on 02/02/2026
- Michael Lavery from Piper Sandler set a target price of $96.0 on 02/02/2026
- Dara Mohsenian from Morgan Stanley set a target price of $100.0 on 02/02/2026
- Bryan Spillane from B of A Securities set a target price of $100.0 on 02/02/2026
- Filippo Falorni from Citigroup set a target price of $105.0 on 02/02/2026
- Andrea Teixeira from JP Morgan set a target price of $97.0 on 02/02/2026
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $CL ticker page for more data.
